Shigeji Ohki

Title: Shigeji Ohki: Innovator in Anti-HIV Compounds

Introduction

Shigeji Ohki is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as synthetic intermediates for anti-HIV agents. With a total of 2 patents to his name, Ohki's work is crucial in the ongoing fight against HIV.

Latest Patents

Ohki's latest patents focus on the production of 4-oxoquinoline compounds. The first patent describes a process for producing a compound that is useful as a synthetic intermediate for an anti-HIV agent with integrase inhibitory activity. This invention provides various compounds represented by specific formulas, where R can be a fluorine atom or a methoxy group, among other variations. The second patent also outlines a method for producing a 4-oxoquinoline compound, emphasizing its utility in synthesizing anti-HIV agents.

Career Highlights

Shigeji Ohki is currently employed at Japan Tobacco Inc., where he continues to innovate in the field of pharmaceutical chemistry. His work has garnered attention for its potential applications in developing effective treatments for HIV.

Collaborations

Ohki has collaborated with notable coworkers, including Koji Matsuda and Koji Ando. Their combined expertise contributes to the advancement of research in medicinal compounds.

Conclusion

Shigeji Ohki's contributions to the field of anti-HIV compounds highlight the importance of innovation in pharmaceutical research. His patents reflect a commitment to developing effective treatments that can make a difference in the lives of those affected by HIV.